Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Dexamethasone Phosphate Delivered by Ocular Iontophoresis for the Treatment of Dry Eye in the Controlled Adverse Environment (CAE) Model

NCT01129856 is registered in ClinicalTrials.gov with Eyegate Pharmaceuticals, Inc. as lead sponsor.

NCT NCT01129856
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01129856 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Dexamethasone Phosphate Delivered by Ocular Iontophoresis for the Treatment of Dry Eye in the Controlled Adverse Environment (CAE) Model
Lead sponsor
Eyegate Pharmaceuticals, Inc.
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2010
Completion date
April 30, 2011
Enrollment
198 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye